Hasan A., Falkai P., Wobrock T., Lieberman J., Glenthøj B., Gattaz W.F., Thibaut F., Möller H.J., Mosolov S.N.Hasan A.Hasan A., Falkai P., Wobrock T., Lieberman J., Glenthøj B., Gattaz W.F., Thibaut F., Möller H.J., Mosolov S.N., Falkai P.Hasan A., Falkai P., Wobrock T., Lieberman J., Glenthøj B., Gattaz W.F., Thibaut F., Möller H.J., Mosolov S.N., Wobrock T. et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia – a Short Version for Primary Care // International Journal of Psychiatry in Clinical Practice. 2017. Vol. 21, № 2. P. 82-90.

Ключевые слова: - - - -

Hasan A., Falkai P., Wobrock T., Mosolov S.N.Hasan A.Hasan A., Falkai P., Wobrock T., Mosolov S.N., Falkai P.Hasan A., Falkai P., Wobrock T., Mosolov S.N., Wobrock T. et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia
and management of antipsychotic-induced side effects // The World Journal of Biological Psychiatry. 2013. N 14. P. 2–4.

Ключевые слова: - - - -